Companies › Signet Therapeutics

Signet Therapeutics

Futian, China · ≈30 employees · signettx.com

Signet Therapeutics is a cutting-edge firm that conducts research and development on cancer-targeted drugs using AI and organoid disease models.

Professional Services Healthcare Biotechnology Research and Development Services

Funding0

Every round, secondary, debt facility or acquisition involving Signet Therapeutics that Lounge tracks, newest first.

No rounds recorded yet.

Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.

See plans →Log in

Signet Therapeutics

Funding0

Key numbers

Similar companies